{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:19:45Z","timestamp":1790443185996,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cca.2020.10.007","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T11:38:12Z","timestamp":1602502692000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Combined analysis of plasma or serum glucosylsphingosine and globotriaosylsphingosine by UPLC-MS\/MS"],"prefix":"10.1016","volume":"511","author":[{"given":"James","family":"Beasley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McCaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee R.","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2020.10.007_b0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.cca.2020.10.007_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A Review of Gaucher Disease Pathophysiology Clinical Presentation and Treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cca.2020.10.007_b0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1615\/CritRevOncog.2013006060","article-title":"Gaucher disease: a comprehensive review","volume":"18","author":"Rosenbloom","year":"2013","journal-title":"Crit. Rev. Oncog."},{"issue":"4","key":"10.1016\/j.cca.2020.10.007_b0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch."},{"issue":"19","key":"10.1016\/j.cca.2020.10.007_b0025","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1021\/ac401542k","article-title":"A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients","volume":"85","author":"Manwaring","year":"2013","journal-title":"Anal. Chem."},{"issue":"11","key":"10.1016\/j.cca.2020.10.007_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.cca.2020.10.007_b0035","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cca.2020.10.007_b0040","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.cca.2020.10.007_b0045","first-page":"811","article-title":"Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Lipids"},{"issue":"3","key":"10.1016\/j.cca.2020.10.007_b0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2020.10.007_b0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","article-title":"Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease","volume":"53","author":"Aerts","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"8","key":"10.1016\/j.cca.2020.10.007_b0060","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cca.2020.10.007_b0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2015.07.026","article-title":"Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool","volume":"450","author":"Fuller","year":"2015","journal-title":"Clin. Chim. Acta."},{"issue":"3","key":"10.1016\/j.cca.2020.10.007_b0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2020.04.006","article-title":"A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females","volume":"130","author":"Stiles","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.cca.2020.10.007_b0075","first-page":"293","article-title":"Quantitative determination of glycosphingolipids in human plasma","volume":"15","author":"Atzpodien","year":"1977","journal-title":"J. Clin. Chem. Clin. Biochem. Zeitschrift fur klinische Chemie und klinische Biochemie."},{"issue":"3","key":"10.1016\/j.cca.2020.10.007_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-2275(20)41686-4","article-title":"Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives","volume":"18","author":"Ullman","year":"1977","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.cca.2020.10.007_b0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/metabo2010134","article-title":"Lipidomics of glycosphingolipids","volume":"2","author":"Farwanah","year":"2012","journal-title":"Metabolites."},{"key":"10.1016\/j.cca.2020.10.007_b0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cca.2012.09.026","article-title":"LC-MS\/MS analysis of plasma lyso-Gb3 in Fabry disease","volume":"414","author":"Boutin","year":"2012","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cca.2020.10.007_b0095","article-title":"Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients","volume":"90","author":"Boutin","year":"2016","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"3","key":"10.1016\/j.cca.2020.10.007_b0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2020.10.007_b0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcmd.2015.01.006","article-title":"Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard","volume":"54","author":"Mirzaian","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.cca.2020.10.007_b0110","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease","volume":"88","author":"Boutin","year":"2016","journal-title":"Anal. Chem."},{"issue":"16","key":"10.1016\/j.cca.2020.10.007_b0115","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1021\/acs.analchem.7b01442","article-title":"Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease","volume":"89","author":"Hamler","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2020.10.007_b0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1570-0232(02)00244-1","article-title":"Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods","volume":"774","author":"Almeida MMC-B","year":"2002","journal-title":"J. Chromatogr. B."},{"issue":"2","key":"10.1016\/j.cca.2020.10.007_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2017.12.431","article-title":"Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature","volume":"123","author":"Voorink-Moret","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2020.10.007_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2019.03.009","article-title":"Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients","volume":"494","author":"Chuang","year":"2019","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cca.2020.10.007_b0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.microc.2012.02.011","article-title":"Mass Spectrometry-Based Multiplexing for the Analysis of Biomarkers in Drug Development and Clinical Diagnostics- How Much is too Much?","volume":"105","author":"Christians","year":"2012","journal-title":"Microchem. J."},{"key":"10.1016\/j.cca.2020.10.007_b0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trac.2014.04.017","article-title":"Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry","volume":"61","author":"Cajka","year":"2014","journal-title":"Trends Analyt. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120304897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120304897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:56:14Z","timestamp":1757861774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120304897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"alternative-id":["S0009898120304897"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.10.007","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined analysis of plasma or serum glucosylsphingosine and globotriaosylsphingosine by UPLC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}